Literature DB >> 8703706

Is there any reason to lower proteinuria in a child with nephrotic-range proteinuria who is not clinically edematous?

D Kees-Folts1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703706     DOI: 10.1007/BF00862069

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  17 in total

1.  Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children.

Authors:  P Tarshish; J Bernstein; J N Tobin; C M Edelmann
Journal:  Pediatr Nephrol       Date:  1992-03       Impact factor: 3.714

2.  Use of angiotensin converting enzyme inhibitors for the treatment of focal segmental glomerulosclerosis.

Authors:  D S Fitzwater; B H Brouhard; R J Cunningham
Journal:  Am J Dis Child       Date:  1990-05

3.  Structural-functional correlations in renal disease. II. The correlations.

Authors:  L I Schainuck; G E Striker; R E Cutler; E P Benditt
Journal:  Hum Pathol       Date:  1970-12       Impact factor: 3.466

4.  Reduction of albuminuria after angiotensin converting enzyme inhibition in various renal disorders.

Authors:  J Kurkus; H Thysell
Journal:  Scand J Urol Nephrol       Date:  1990

5.  A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome.

Authors:  A A Eddy; L McCulloch; E Liu; J Adams
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

6.  Cholesterol: a renal risk factor in diabetic nephropathy?

Authors:  H Mulec; S A Johnsen; O Wiklund; S Björck
Journal:  Am J Kidney Dis       Date:  1993-07       Impact factor: 8.860

7.  Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome.

Authors:  D S Milliner; B Z Morgenstern
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

8.  Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.

Authors:  J R Diamond; N A Hanchak; M D McCarter; M J Karnovsky
Journal:  Am J Clin Nutr       Date:  1990-04       Impact factor: 7.045

9.  Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor.

Authors:  T Keilani; W A Schlueter; M L Levin; D C Batlle
Journal:  Ann Intern Med       Date:  1993-02-15       Impact factor: 25.391

10.  The role of the interstitium of the renal cortex in renal disease.

Authors:  A Bohle; H Christ; K E Grund; S Mackensen
Journal:  Contrib Nephrol       Date:  1979       Impact factor: 1.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.